Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hualu Pharmaceutical Co., Ltd. is a large-scale pharmaceutical manufacturer based in Liaocheng, China, and a key subsidiary of the state-owned Hualu Holdings Group. The company specializes in the production of large-volume parenterals (LVP), small-volume injections, and solid oral dosage forms such as tablets, capsules, and granules. With a portfolio of over 200 drug varieties, Hualu focuses on therapeutic areas including anti-infectives, cardiovascular health, neurology, and metabolic diseases. The company is particularly recognized for its significant manufacturing capacity in the infusion market and its active engagement in bioequivalence studies for generic medications. Hualu Pharmaceutical serves both domestic and international markets, maintaining high standards of GMP-compliant production and supply chain reliability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hualu Pharmaceutical.